John Petrides, MD and portfolio manager at Point View Wealth Management, says it might not be a wise decision to follow Bill Ackman into Valeant stock.
Leadership
VIDEO: Should investors take a cue from Bill Ackman?
John Petrides, MD and portfolio manager at Point View Wealth Management, says it might not be a wise decision to follow Bill Ackman into Valeant stock.
You May Also Like
World News
In the 15th Nov 2015 edition of Israel’s good news, the highlights include: · A new Israeli treatment brings hope to relapsed leukemia...
Life-Style Health
Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars
Entertainment
The Movie The Professional is what made Natalie Portman a Lolita.
Travel
After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published. Invited to place bids...